Alphagan p and Haematoma - a phase IV clinical study of FDA data

Summary:

Haematoma is reported as a side effect among people who take Alphagan p (brimonidine tartrate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Symbicort, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Haematoma when taking Alphagan p. It is created by eHealthMe based on reports of 6,484 people who have side effects when taking Alphagan p from the FDA, and is updated regularly.

What is Alphagan p?

Alphagan p has active ingredients of brimonidine tartrate. It is often used in glaucoma. eHealthMe is studying from 6,579 Alphagan p users. Check the latest studies of Alphagan p.

What is Haematoma?

Haematoma (collection of blood outside the blood vessels) is found to be associated with 1,451 drugs and 2,018 conditions by eHealthMe. Check the latest studies of Haematoma.

On Jul, 16, 2026

6,484 people reported to have side effects when taking Alphagan p.
Among them, 16 people (0.25%) have Haematoma.

Among these 16 people:

How long have people been on Alphagan p when they have Haematoma? *

What is the gender of people who have Haematoma when taking Alphagan p? *

female: 68.75 %
male: 31.25 %

What is the age of people who have Haematoma when taking Alphagan p? *

What are other drugs people take besides Alphagan p? *

What are other side effects people have besides Haematoma? *

Pain In Extremity: 9 people, 56.25%
Weakness: 8 people, 50.00%
Fatigue (feeling of tiredness): 8 people, 50.00%
Joint Pain: 7 people, 43.75%
Head Injury: 7 people, 43.75%
Pneumonia: 7 people, 43.75%
Rashes (redness): 7 people, 43.75%
Wound: 6 people, 37.50%
Nasopharyngitis (inflammation of the nasopharynx): 6 people, 37.50%
Fever: 6 people, 37.50%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 37.50%
Pain: 3 people, 18.75%
Stress And Anxiety: 3 people, 18.75%
Type 2 Diabetes: 2 people, 12.50%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 12.50%
Depression: 2 people, 12.50%
Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%
Hypersensitivity: 2 people, 12.50%
Sleep Disorder: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Alphagan p and have Haematoma?

- Check whether Haematoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alphagan p:

Alphagan p (6,579 reports)

Haematoma treatments and more:

Haematoma (31,767 reports)

Browse all side effects of Alphagan p:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haematoma:

Haematoma (1,451 drugs)

Browse all the conditions that are associated with Haematoma:

Haematoma (2,018 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on brimonidine tartrate (the active ingredients of Alphagan p) and Alphagan p (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.